Together, these findings demonstrate that the inflammatory and immunosuppressive signatures detected in our multi-cohort analyses are robust across both expression-based and infiltration-based estimation methods, highlighting the complex interplay between COX-2, PD-L1, and the immune microenvironment in CRC. This evidence concerns the gene PTGS2 and colorectal carcinoma.